Defence Therapeutics Inc. (CSE:DTC)
Canada
· Delayed Price · Currency is CAD 0.9700
-0.0700 (-6.73%)
Apr 4, 2025, 1:56 PM EST
Defence Therapeutics Balance Sheet
Financials in millions CAD. Fiscal year is July - June.
Millions CAD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 |
Cash & Equivalents | 0.13 | 0.06 | 2.79 | 0.51 | 5.45 | 1.87 | Upgrade
|
Cash & Short-Term Investments | 0.13 | 0.06 | 2.79 | 0.51 | 5.45 | 1.87 | Upgrade
|
Cash Growth | -62.81% | -97.97% | 451.20% | -90.71% | 192.24% | 243493.60% | Upgrade
|
Other Receivables | 0.05 | 0.1 | 0.15 | 0.03 | 0.07 | - | Upgrade
|
Receivables | 0.05 | 0.1 | 0.15 | 0.03 | 0.07 | - | Upgrade
|
Prepaid Expenses | 0.02 | 0.06 | 0.49 | 0.14 | 0.04 | - | Upgrade
|
Total Current Assets | 0.19 | 0.21 | 3.43 | 0.67 | 5.56 | 1.87 | Upgrade
|
Property, Plant & Equipment | 0.21 | 0.26 | 0.06 | - | - | - | Upgrade
|
Other Intangible Assets | - | - | 0.04 | 0.05 | 0.05 | 0.05 | Upgrade
|
Total Assets | 0.4 | 0.48 | 3.53 | 0.72 | 5.61 | 1.91 | Upgrade
|
Accounts Payable | 2.25 | 2.09 | 0.19 | 0.98 | 0.11 | 0.05 | Upgrade
|
Short-Term Debt | 0.02 | 0.05 | - | - | - | - | Upgrade
|
Current Portion of Long-Term Debt | 1.25 | 1.66 | - | - | - | - | Upgrade
|
Current Portion of Leases | 0.02 | 0.03 | - | - | - | - | Upgrade
|
Other Current Liabilities | 0.33 | 0.22 | 0.03 | 0.13 | 0.01 | - | Upgrade
|
Total Current Liabilities | 3.86 | 4.05 | 0.22 | 1.11 | 0.12 | 0.05 | Upgrade
|
Long-Term Debt | - | - | 1.75 | - | - | - | Upgrade
|
Long-Term Leases | - | 0.01 | - | - | - | - | Upgrade
|
Total Liabilities | 3.86 | 4.06 | 1.97 | 1.11 | 0.12 | 0.05 | Upgrade
|
Common Stock | 20.24 | 19.24 | 16.95 | 9.33 | 7.97 | 2.4 | Upgrade
|
Retained Earnings | -28.07 | -29.81 | -16.91 | -10.52 | -3.53 | -0.67 | Upgrade
|
Comprehensive Income & Other | 4.37 | 6.98 | 1.52 | 0.79 | 1.05 | 0.14 | Upgrade
|
Shareholders' Equity | -3.45 | -3.58 | 1.57 | -0.39 | 5.49 | 1.86 | Upgrade
|
Total Liabilities & Equity | 0.4 | 0.48 | 3.53 | 0.72 | 5.61 | 1.91 | Upgrade
|
Total Debt | 1.28 | 1.75 | 1.75 | - | - | - | Upgrade
|
Net Cash (Debt) | -1.15 | -1.69 | 1.05 | 0.51 | 5.45 | 1.87 | Upgrade
|
Net Cash Growth | - | - | 106.61% | -90.71% | 192.24% | 243493.60% | Upgrade
|
Net Cash Per Share | -0.03 | -0.04 | 0.03 | 0.01 | 0.21 | 1.98 | Upgrade
|
Filing Date Shares Outstanding | 54.73 | 45.54 | 44.27 | 37.68 | 35.96 | 18.47 | Upgrade
|
Total Common Shares Outstanding | 47.7 | 45.54 | 43.78 | 36.63 | 35.22 | 18.47 | Upgrade
|
Working Capital | -3.66 | -3.84 | 3.21 | -0.43 | 5.44 | 1.82 | Upgrade
|
Book Value Per Share | -0.07 | -0.08 | 0.04 | -0.01 | 0.16 | 0.10 | Upgrade
|
Tangible Book Value | -3.45 | -3.58 | 1.53 | -0.43 | 5.44 | 1.82 | Upgrade
|
Tangible Book Value Per Share | -0.07 | -0.08 | 0.03 | -0.01 | 0.15 | 0.10 | Upgrade
|
Machinery | 0.25 | 0.27 | 0.07 | - | - | - | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.